Expression of an early myelopoietic antigen (CD33) on a subset of human umbilical cord blood-derived natural killer cells.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 7505004)

Published in Immunol Lett on August 01, 1993

Authors

R Handgretinger1, H J Schäfer, F Baur, D Frank, C Ottenlinger, H J Bühring, D Niethammer

Author Affiliations

1: Children's University Hospital, Department of Hematology/Oncology, University of Tübingen, Germany.

Articles by these authors

How well do patients take oral penicillin? A collaborative study in private practice. Pediatrics (1967) 5.82

Sp1 elements protect a CpG island from de novo methylation. Nature (1994) 5.60

A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet (2001) 5.06

CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol (1987) 4.58

Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA (2001) 3.55

Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res (1997) 3.55

Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci U S A (1997) 2.88

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia (2009) 2.78

Procyclin gene expression and loss of the variant surface glycoprotein during differentiation of Trypanosoma brucei. J Cell Biol (1989) 2.60

Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing. Infect Immun (1995) 2.48

Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet (2004) 2.40

The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis. Blood (1998) 2.37

Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am J Physiol (1994) 2.33

Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development (1997) 2.32

The PKD1 gene produces a developmentally regulated protein in mesenchyme and vasculature. Nat Med (1995) 2.30

Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood (1994) 2.11

Progress in chimerism analysis in childhood malignancies--the dilemma of biostatistical considerations and ethical implications. Leukemia (2001) 2.02

Cloned long-term cytolytic T-lymphocyte line with specificity for an immediate-early membrane antigen of murine cytomegalovirus. J Virol (1986) 1.86

Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47. Blood (1999) 1.77

Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Infect Immun (2001) 1.75

Plasma 4beta-hydroxycholesterol: an endogenous CYP3A metric? Clin Pharmacol Ther (2009) 1.66

Inhibition of 3H-thymidine incorporation of lymphocytes by a soluble factor from macrophages. Cell Immunol (1975) 1.65

Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits. J Appl Physiol (1985) (1993) 1.64

Hypoxaemia in children with severe pneumonia in Papua New Guinea. Int J Tuberc Lung Dis (2001) 1.57

The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51, implicated in Fas expression and apoptosis. Hum Mol Genet (1997) 1.56

Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rabbits. Cardiovasc Res (1996) 1.55

Intestinal perforation associated with cytomegalovirus infection in patients with acquired immune deficiency syndrome. Am J Gastroenterol (1984) 1.54

Localization of specific mRNAs in Xenopus embryos by whole-mount in situ hybridization. Development (1990) 1.52

Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood (1991) 1.52

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant (2001) 1.50

The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. Cancer Res (2001) 1.50

Risk of sudden infant death syndrome among infants with in utero exposure to cocaine. J Pediatr (1988) 1.49

Staphylococcus lugdunensis: report of a case of peritonitis and an easy-to-perform screening strategy. J Clin Microbiol (1998) 1.48

Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago. Bone Marrow Transplant (2004) 1.48

Analysis of prepro-alpha-lytic protease expression in Escherichia coli reveals that the pro region is required for activity. J Bacteriol (1989) 1.45

Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells. Blood (2001) 1.44

Biochemical characterization of a factor released by macrophages. Cell Immunol (1975) 1.44

A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a. Cancer Immunol Immunother (1992) 1.44

Cutting edge: signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells. J Immunol (2000) 1.41

Simultaneous expression of CD4 and CD8 antigens by a substantial proportion of resting porcine T lymphocytes. Eur J Immunol (1987) 1.41

Postnatal management of antenatal hydronephrosis. BJU Int (2002) 1.39

Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia (1996) 1.38

IMPT1, an imprinted gene similar to polyspecific transporter and multi-drug resistance genes. Hum Mol Genet (1998) 1.35

Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J Exp Med (1988) 1.34

Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology (2005) 1.34

Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review). Int J Mol Med (1998) 1.31

Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood (1997) 1.30

Effect of in vitro DNA methylation on beta-globin gene expression. Proc Natl Acad Sci U S A (1988) 1.29

Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol (1992) 1.28

Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients. Clin Pharmacol Ther (2008) 1.23

Karyometry in the early detection and chemoprevention of intraepithelial lesions. Eur J Cancer (2005) 1.20

Longitudinal gonadal function after bone marrow transplantation for acute lymphoblastic leukemia during childhood. Pediatr Transplant (1999) 1.18

Competition between noggin and bone morphogenetic protein 4 activities may regulate dorsalization during Xenopus development. Proc Natl Acad Sci U S A (1995) 1.15

Association of signal-regulatory proteins beta with KARAP/DAP-12. Eur J Immunol (2000) 1.13

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Tuebingen experience. Leukemia (2003) 1.12

Scintigraphic imaging of neuroblastoma with [131-I]iodobenzylguanidine. Lancet (1984) 1.12

Specific antibodies elicited by antigen covalently linked to a synthetic adjuvant. Immunobiology (1985) 1.12

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL. Leukemia (2002) 1.11

Identification of high-risk patients with aplastic anaemia in selection for allogeneic 0one-marrow transplantation. Lancet (1976) 1.10

An attempt to produce "pre-T" cell hybridomas and to identify their antigens. Eur J Immunol (1986) 1.10

Cloning sulfur assimilation genes of Brassica juncea L.: cadmium differentially affects the expression of a putative low-affinity sulfate transporter and isoforms of ATP sulfurylase and APS reductase. Plant Mol Biol (1999) 1.09

Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematol Blood Transfus (1990) 1.09

Physical properties and function of phallolysin. Biochemistry (1983) 1.09

Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. J Cell Mol Med (2012) 1.08

Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion. Eur Heart J (1994) 1.08

Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells. Cancer Res (1990) 1.08

Monoclonal antibodies reactive with swine lymphocytes. II. Detection of an antigen on resting T cells down-regulated after activation. J Immunol (1987) 1.08

Treatment of neuroblastoma with metaiodobenzylguanidine: results and side effects. Med Pediatr Oncol (1987) 1.08

The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms. Am J Pathol (2001) 1.08

Aged murine killer T-cell clones acquire specific cytotoxicity for P815 mastocytoma cells. Nature (1984) 1.08

How and when should we monitor chimerism after allogeneic stem cell transplantation? Bone Marrow Transplant (2005) 1.07

XMeis3 protein activity is required for proper hindbrain patterning in Xenopus laevis embryos. Development (2001) 1.07

Atrial fibrillation after bypass surgery: does the arrhythmia or the characteristics of the patients prolong hospital stay? Chest (1998) 1.06

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant (1998) 1.06

Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2007) 1.05

Paraxial-fated mesoderm is required for neural crest induction in Xenopus embryos. Dev Biol (1998) 1.05

Smac mimetics: implications for enhancement of targeted therapies in leukemia. Leukemia (2010) 1.05

[Results of treatment of rhabdomyosarcomas (RMS) in children. A report of the Cooperative Soft Tissue Sarcoma Study (CWS-81) of the Society of Pediatric Oncology]. Klin Padiatr (1986) 1.05

Expression and signal transduction of the FLT3 tyrosine kinase receptor. Acta Haematol (1996) 1.04

The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC Cancer (2006) 1.04

Acute mastoiditis--relevant once again. Infection (1994) 1.03

The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. Blood (1996) 1.03

Genetic evidence for the transcriptional-activating function of Homothorax during adult fly development. Development (2001) 1.02

Acquired methotrexate resistance in lymphoblasts resulting from altered kinetic properties of dihydrofoltate reductase. Eur J Cancer (1977) 1.02

Comparative biological responses of rabbits infected with human T-lymphotropic virus type I isolates from patients with lymphoproliferative and neurodegenerative disease. Int J Cancer (1992) 1.02

Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother (1999) 1.00

Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting. Bone Marrow Transplant (1998) 1.00

Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH. Cancer Res (1985) 1.00

Effect of concentration on the cytotoxic mechanism of doxorubicin--apoptosis and oxidative DNA damage. Biochem Biophys Res Commun (1997) 1.00

The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. J Clin Endocrinol Metab (2005) 0.99

Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78. Blood (1985) 0.99

Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine. Eur J Biochem (1993) 0.99

A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study. Klin Padiatr (2005) 0.98

Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children. Leukemia (1999) 0.98

Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. J Clin Oncol (1999) 0.98

Ras-mediated FGF signaling is required for the formation of posterior but not anterior neural tissue in Xenopus laevis. Dev Biol (2000) 0.98

Analysis of Tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells. Br J Haematol (1997) 0.98

Suicide genes: past, present and future perspectives. Immunol Today (2000) 0.98

Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate. Cancer Res (1983) 0.98